Listen in!
As CCTA and AI-enabled coronary plaque analysis move from “nice to have” to reimbursed standard of care, many programs risk leaving both clinical impact and revenue on the table if they don’t adapt their workflows now. In this case‑study‑driven webinar, a cardiac imaging director and a reimbursement specialist will walk through intriguing CAD cases showing how quantified plaque supports sharper risk stratification, serial plaque tracking, and more confident treatment decisions over time. They’ll also detail exactly how to document, code, and bill – and share strategies for updating workflows to streamline physician effort, reduce reporting burden and stay aligned with evolving payer expectations.
Here’s What We Cover:
- The advantages of an in-house plaque analysis tool that offers immediate evaluation and no outsourced processing delays
- How hospitals and physicians can add approximately $950–$1,000 per qualifying CCTA study
- Why facilities are performing plaque analysis when they don’t plan to bill for it
- How AI plaque analysis integrates into CCTA workflow with minimal added physician time
- Inside CPT 75577’s category one designation and its significance for AI diagnostic billing
- CMS and commercial payer medical necessity criteria for coronary plaque quantification
- The operational roadmap for turning clinical capability into reliable, incremental revenue
Who Should Watch:
- Cardiologists and Interventional Cardiologists
- Cardiovascular Imaging Specialists
- Radiologists
- VPs, Directors and Managers, Cardiovascular Service Line
- VPs, Directors and Managers, Radiology and Imaging
- Cath Lab Directors
- CV Nurses, NPs, PAs
- CT Technologists
- Billing specialists
- Internal medicine physicians
Expert Panel:
| 
|